Biotech 2050 Podcast cover image

Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics

Biotech 2050 Podcast

CHAPTER

Current State and Future Prospects of Affini-T Therapeutics in the Solid Tumor Space

This chapter provides insights into the current state of Affini-T Therapeutics, including their employee count, upcoming IND filings, and focus on cell therapy to target KRAS G12C. It also highlights their partnership with Elevate Bio and their pioneering work in gene editing.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner